secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0001654954-26-000712
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv FY2025 revenue $9.0M (down ~5% YoY), net loss $0.1M; declares $0.075 special dividend
--------------------------------------------------------------------------------

- Revenue $9.0M, decrease of $0.5M YoY; net loss $0.1M, improvement of $0.7M from prior year.
- Special dividend of $0.075 per share approved; payable March 20, 2026 to holders of record Feb 27, 2026.
- CEO cites portfolio rationalization, cost streamlining, and focus on Latin America and Europe for 2026.
- Company traded on OTCQB under ticker PBSV; no explicit guidance provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495426000712/0001654954-26-000712-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495426000712/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-26-000712

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer